<DOC>
	<DOCNO>NCT00269971</DOCNO>
	<brief_summary>The purpose study determine effective dose epoetin alfa administer prior surgery , decrease need blood transfusion hip replacement . Epoetin alfa genetically engineer protein stimulates red blood cell production .</brief_summary>
	<brief_title>A Study Determine Effective Dose Epoetin Alfa Decrease Number Units Blood Required Transfused During Hip Replacement Surgery .</brief_title>
	<detailed_description>Major surgical procedure may require blood transfusion operation . Agents increase rate red blood cell production would reduce need blood transfusion . Epoetin alfa genetically engineer form natural hormone , erythropoietin , stimulates red blood cell production . This randomized , double-blind , multicenter study patient schedule first time hip replacement surgery . The study compare effectiveness 2 different dos epoetin alfa ( 20,000 unit 40,000 unit per week ) reduce need blood transfusion surgery . Eligible patient randomly assign one three treatment group : epoetin alfa 20,000 unit per week , epoetin alfa 40,000 unit per week , placebo . Patients treat study medication week 4 week schedule surgery . Effectiveness determine number transfusion require surgery . Other factor determine effectiveness : level hemoglobin ( oxygen-carrying component red blood cell ) percentage red blood cell patient 's blood ( hematocrit ) prior surgery ; number develop red blood cell ( reticulocyte ) ; iron store patient 's blood prior surgery ; patient 's quality life surgery ; time elapse surgery patient discharge hospital . Safety evaluation include incidence blood clot deep vein , incidence severity adverse event , change clinical laboratory test , vital sign , physical examination finding throughout study . The study hypothesis patient treat epoetin alfa hip replacement surgery require few blood transfusion surgery compare patient treat placebo , low epoetin alfa dose ( 20,000 unit per week ) effective high epoetin alfa dose ( 40,000 unit per week ) . Patients receive 20,000 unit 40,000 unit epoetin alfa inject skin weekly 4 week , match placebo injection contain human serum albumin .</detailed_description>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patients schedule firsttime hip replacement surgery major medical condition hemoglobin level 98 137 gram per liter adequate iron store participate selfdonated blood program Patients history rheumatoid arthritis , blood disorder , recent bleed episode iron deficiency history seizure uncontrolled high blood pressure ( diastolic blood pressure &gt; 100 mmHg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>hip replacement</keyword>
	<keyword>hip replacement surgery</keyword>
	<keyword>surgery</keyword>
	<keyword>anemia</keyword>
	<keyword>transfusion</keyword>
	<keyword>blood</keyword>
	<keyword>blood transfusion</keyword>
</DOC>